» Articles » PMID: 26097602

Prognostic Significance of Long Non-coding RNA PCAT-1 Expression in Human Hepatocellular Carcinoma

Overview
Specialty Pathology
Date 2015 Jun 23
PMID 26097602
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Long non-coding RNAs (lncRNAs) play widespread roles in gene regulation and cellular processes. However, the functional roles of lncRNAs in hepatocellular carcinoma (HCC) are not yet well elucidated. The aim of the present study was to measure the levels of lncRNA PCAT-1 expression in HCC and evaluate its clinical significance in the development and progression of HCC.

Methods: We examined the expression of PCAT-1 in 117 HCC tissues and adjacent non-tumor tissues using quantitative real-time-PCR and analyzed its correlation with the clinical parameters.

Results: Our data showed that PCAT-1 expression in HCC tissues was significantly increased compared with adjacent non-tumor tissues (P<0.05). Up-regulated expression of PCAT-1 was significantly associated with TNM stage and metastasis (P<0.05), but not other clinical parameters. Moreover, Kaplan-Meier survival analysis showed that a high expression level of PCAT-1 resulted in a significantly poor overall survival of HCC patients. The multivariate Cox regression analysis demonstrated that PCAT-1 expression level was an independent prognostic factor for the overall survival rate of HCC patients.

Conclusions: Our data suggested that the increased expression of PCAT-1 was associated with advanced clinical parameters and poor overall survival of HCC patients, indicating that PCAT-1 up-regulation may serve as a novel biomarker of poor prognosis in HCC patients.

Citing Articles

Circulating exosomal PCAT1 as a complement of carcinoembryonic antigen for early colorectal cancer diagnosis.

Cao J, Chao W, Zhang J, Mao J, Zeng J, Luo D Heliyon. 2024; 10(20):e39264.

PMID: 39640681 PMC: 11620264. DOI: 10.1016/j.heliyon.2024.e39264.


The Association between Long Noncoding RNA over Expression and Poor Prognosis of Liver Cancer: A Meta-Analysis.

Wang L, Sheng J, Zhang H, Xie B, Xiang L, Liu D J Healthc Eng. 2022; 2021:1395131.

PMID: 35419184 PMC: 8995546. DOI: 10.1155/2021/1395131.


Long non-coding RNAs involved in different steps of cancer metastasis.

Suman P, Chhichholiya Y, Kaur P, Ghosh S, Munshi A Clin Transl Oncol. 2022; 24(6):997-1013.

PMID: 35119654 DOI: 10.1007/s12094-021-02761-z.


Functional roles of lncRNAs in the pathogenesis and progression of cancer.

Ahadi A Genes Dis. 2021; 8(4):424-437.

PMID: 34179307 PMC: 8209321. DOI: 10.1016/j.gendis.2020.04.009.


The Role of RNA in DNA Breaks, Repair and Chromosomal Rearrangements.

Murashko M, Stasevich E, Schwartz A, Kuprash D, Uvarova A, Demin D Biomolecules. 2021; 11(4).

PMID: 33918762 PMC: 8069526. DOI: 10.3390/biom11040550.


References
1.
Greene F . The American Joint Committee on Cancer: updating the strategies in cancer staging. Bull Am Coll Surg. 2007; 87(7):13-5. View

2.
El-Serag H, Rudolph K . Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007; 132(7):2557-76. DOI: 10.1053/j.gastro.2007.04.061. View

3.
El-Serag H, Marrero J, Rudolph L, Reddy K . Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008; 134(6):1752-63. DOI: 10.1053/j.gastro.2008.02.090. View

4.
Llovet J, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc J . Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008; 359(4):378-90. DOI: 10.1056/NEJMoa0708857. View

5.
Mercer T, Dinger M, Mattick J . Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009; 10(3):155-9. DOI: 10.1038/nrg2521. View